Texas woman admits selling patient information stolen from EHR

A Texas woman has pleaded guilty for her role in a multimillion-dollar conspiracy involving the sale of forged prescriptions, the Department of Justice announced March 25. 

Advertisement

Lydia Henslee, 29, of Denison, Texas, pleaded guilty to conspiring to possess and use means of identification in connection with various offenses after being indicted by a federal grand jury in September 2019. 

According to information presented to the court, Ms. Henslee and her co-conspirators breached a healthcare provider’s EHR system to steal patients’ protected health information and personal information. The stolen information was then included in fraudulent physician orders and sold to durable medical equipment providers. 

The defendants allegedly received more than $1.4 million from selling the stolen information over an eight-month period. 

In 2020, Ms. Henslee was also charged for her role in an alleged scheme that involved paying and receiving kickbacks in exchange for orders from physicians. 

Ms. Henslee faces up to 15 years in federal prison. 

More articles on legal and regulatory issues:
Indiana nurse charged with felony after COVID-19 patient’s death
New Jersey health system sues insurer over $2.5B policy payout
Man who crashed car into Ohio hospital pleads guilty to murder

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.